PRURIGO NODULARIS
Clinical trials for PRURIGO NODULARIS explained in plain language.
Never miss a new study
Get alerted when new PRURIGO NODULARIS trials appear
Sign up with your email to follow new studies for PRURIGO NODULARIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a brief mind therapy stop the Itch-Scratch cycle?
Symptom relief CompletedThis study tested whether adding a short psychological therapy (called EMD-U) to usual care could improve life quality for adults with eczema or prurigo nodularis who have severe scratching problems. The therapy combines techniques from different talk therapies to help reduce the…
Matched conditions: PRURIGO NODULARIS
Phase: NA • Sponsor: Tamar Nijsten • Aim: Symptom relief
Last updated Mar 30, 2026 14:33 UTC
-
New cream shows promise for debilitating skin itch
Symptom relief CompletedThis study tested a cream called ruxolitinib to see if it safely reduces severe itch and improves skin lesions in people with prurigo nodularis, a chronic skin condition. 190 participants with intense, long-lasting itch applied the cream or a placebo for 12 weeks, followed by an …
Matched conditions: PRURIGO NODULARIS
Phase: PHASE3 • Sponsor: Incyte Corporation • Aim: Symptom relief
Last updated Mar 25, 2026 14:08 UTC
-
New shot targets debilitating itch of skin condition
Symptom relief CompletedThis study tested whether an injectable drug called vixarelimab (KPL-716) could safely reduce severe itching and improve skin lesions in adults with prurigo nodularis. About 240 participants with moderate to severe symptoms received either the drug or a placebo for 8 to 16 weeks …
Matched conditions: PRURIGO NODULARIS
Phase: PHASE2 • Sponsor: Genentech, Inc. • Aim: Symptom relief
Last updated Mar 23, 2026 15:15 UTC